STAT3 acts as a transcription factor with anti-apoptotic as well as proliferative effects and additionally, its activation in T-LGL leukemia patients correlates with FasL (Fas ligand) levels, explaining the occurrence of neutropenia in these patients (3). Here, FASLG is linked to neutropenia.